We are on a journey to save the sight and improve the health of millions.
We develop and commercialize innovative and
non-invasive oximetry technologies revolutionizing eye care
Our solution uses the power of light to provide researchers and eye-care professionals with crucial information on the metabolic state of ocular tissues and on processes involved in ocular diseases.
Our all-in-one solution
Our technological platform — combining device, software and data management — enables researchers and eye-care professionals to gain insight into metabolic and pathophysiological processes.
Our user-friendly, cloud-based, interactive analytical software powered by artificial intelligence provides robust and accurate data used for the screening, assessment and monitoring of diseases** such as glaucoma, diabetic retinopathy and age-related macular degeneration.
USA: **Caution—Investigational Device, Limited by Federal (or the United States) Law to Investigational Use” The Zilia Ocular device is not cleared by the Food and Drug Administration (FDA) and is not offered for sale in the USA. Please contact Zilia directly to obtain the device for investigation use only. Zilia may support your clinical investigation activities on such diseases.
EU and Canada : **Investigational Device only, not for clinical use. The Zilia Ocular device is not CE marked or didn’t received Health Canada homologation and is not offered for sale in the European Union nor Canada. Please contact Zilia directly to obtain the device for investigational use only. Zilia may support your clinical investigation
475 Grande-Allée Est
G1R 2J5, CANADA